Thu, Nov 27, 2014, 5:03 PM EST - U.S. Markets closed for Thanksgiving Day

Recent

% | $
Quotes you view appear here for quick access.

Genomic Health Inc. Message Board

  • rosemariecorbin rosemariecorbin Dec 10, 2012 9:42 AM Flag

    in play:8:03AM Genomic Health reports results from six studies demonstrating unique value of the Oncotype DX breast cancer test in early stage breast cancer

    8:03AM Genomic Health reports results from six studies demonstrating unique value of the Oncotype DX breast cancer test in early stage breast cancer (GHDX) 27.69 : Co announced the results from six studies of the Oncotype DX breast cancer test presented at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) reinforcing the impact of the test on facilitating better informed treatment decisions in patients with node-negative and node-positive invasive early-stage breast cancer. Additionally, two studies demonstrated the test's cost effectiveness in invasive breast cancer and ductal carcinoma in situ (DCIS), adding to the large body of evidence of Oncotype DX's economic value across various healthcare systems. Studies continue to reinforce Oncotype DX provides important individualized information that can not be revealed by traditional measures alone.

 
GHDX
32.37-0.46(-1.40%)Nov 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.